Part 5/8:
Unfortunately, the World Health Organization highlights that antivenom remains in short supply, particularly in developing countries where snake bites are most prevalent. The high production costs and logistical challenges mean many venomous bites go untreated, leading to death or permanent disability.
Jim and Kristen's work plays a pivotal role in addressing this gap. Not only do they produce venom crucial for worldwide antivenom manufacturing, but they also contribute to medical research exploring venom's potential use in treating diseases such as cancer, lupus, and Alzheimer's.